Migraine Question of the Week, 3/16/11
Our readers ask some great questions about Migraine disease and other headache disorders here on MyMigraineConnection. Nancy and I both answer questions in our community question and answer section. Dr. Krusz and I answer other questions in our Ask the Clinician column.
Some of the questions apply to many of our readers, and are great topics for discussion. So, every week, I bring you our Question of the Week. I hope you'll take a few minutes to look at these questions and the answers, then join us in discussion. One of the best things about online communities is the opportunity to share information and experiences.
This week's Question of the Week:
Can someone explain the new FDA warnings on Topamax?
My wife takes it for migraine and I have a science background. Over the entire use of Topamax for a decade, it seems like 4 cases is a very small number. The warning is quite scary though and makes it seem like a lot more data is out there, but the FDA only points to the North American Anti-epileptic Registry and one in the UK in the prescribing information. What doses were used in these 4 cases or the ones from the UK?
Here are some extra links for you:
- Migraine and Headache Specialists - What's So Special?
- Patient Recommended Migraine and Headache Specialists
- Do you have questions? We have answers. Find the three places to ask questions on our Migraine Answers page.
Get the latest Migraine and headache news, informational articles, tips for living well, and more in my free weekly newsletter. To subscribe, CLICK HERE.